-------------------------------------------
“We have been investigating personalized, stem-cell based therapies that reprogram a patient’s own cells to treat their Parkinson’s,” said Kwang-Soo Kim, PhD, at the Molecular Neurobiology Laboratory at McLean Hospital. “
"We have now made a major breakthrough using immune cells to improve delivery, survival, and recovery for neuronal cell therapies. Our findings show the power and flexibility of cell therapy to be modified and enhanced to become a realistic modality to treat conditions like Parkinson’s.”